Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

Saved in:

Bibliographic Details
Main Authors:	Mariko Ogawa‐Momohara (Author), Yoshinao Muro (Author), Takuya Takeichi (Author), Masashi Akiyama (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000 am a22000003u 4500
001	doaj_bd2a692e7b1e42b9a873d6e2fbfbb5a2
042			\|a dc
100	1	0	\|a Mariko Ogawa‐Momohara \|e author
700	1	0	\|a Yoshinao Muro \|e author
700	1	0	\|a Takuya Takeichi \|e author
700	1	0	\|a Masashi Akiyama \|e author
245	0	0	\|a Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits
260			\|b Frontiers Media S.A., \|c 2020-10-01T00:00:00Z.
500			\|a 2574-4593
500			\|a 10.1002/cia2.12132
546			\|a EN
690			\|a Dermatology
690			\|a RL1-803
690			\|a Immunologic diseases. Allergy
690			\|a RC581-607
655	7		\|a article \|2 local
786	0		\|n Journal of Cutaneous Immunology and Allergy, Vol 3, Iss 5, Pp 120-121 (2020)
787	0		\|n https://doi.org/10.1002/cia2.12132
787	0		\|n https://doaj.org/toc/2574-4593
856	4	1	\|u https://doaj.org/article/bd2a692e7b1e42b9a873d6e2fbfbb5a2 \|z Connect to this object online.